UCSF Weill Institute for Neurosciences UCSF.edu
UCSF Department of Neurology

Decoding lysosomal biology to outpace neurodegeneration.

The Sampognaro Lab studies how lysosomal proteases and the autophagy-lysosome system contribute to ALS, frontotemporal dementia, Parkinson's disease, and Alzheimer's disease. Our goal is to turn that understanding into new therapies.

The core mechanism

What happens when the lysosome can't keep up

Neurons constantly produce misfolded proteins like TDP-43, APP, and tau. Normally, the lysosome's cathepsin enzymes cut them apart and clear them. Our research asks what happens, and what can be done, when that clearance step fails.

Diagram: how lysosomal proteases clear misfolded proteins, or fail to A misfolded protein is captured by an autophagosome and delivered to the lysosome. With healthy cathepsins and acidic pH, it is cleared into harmless fragments. With disease mutations or elevated lysosomal pH, clearance fails and the protein accumulates into a larger toxic aggregate. Misfolded protein TDP-43 · APP · tau Autophagosome double membrane closes around it Lysosome six cathepsins cut it apart Healthy clearance acidic pH, normal cathepsins Clearance fails mutation or elevated lysosomal pH
How we work

Advanced models, close to the biology of disease

Our research is powered by advanced experimental approaches, in conjunction with biochemical techniques and confocal microscopy for detailed molecular and cellular analysis.

Confocal image of a brain organoid from the Sampognaro Lab, showing a dense network of neurons in red
Brain organoid, confocal microscopy.
Cell models

iPSC-derived cortical neurons

Human induced pluripotent stem cell models let us study disease-relevant proteins in a neuron's native context.

Cell models

iPSC-derived motor neurons

Motor neuron models directly relevant to ALS, used to probe lysosomal dysfunction and protein clearance.

3D systems

Mature brain organoids

Complex, three-dimensional neural tissue that captures cell-cell interactions a dish alone cannot.

Research focus

Three diseases, one converging mechanism

The core objective of the lab's work is to illuminate the mechanisms underlying lysosomal dysfunction in neurodegenerative disease and identify promising candidates for therapeutic development.

Latest publication

Lysosomal protease-mediated APP degradation is pH-dependent, mutation-sensitive, and facilitates tau proteolysis

Ackley C, Liau Z, Arya S, Antee T, Cheang E, Knudsen GM, Lane-Donovan C, Sampognaro PJ, Kao AW. Molecular Neurodegeneration Advances. 2026;2(1):10.

Read on PubMed →  ยท  All publications →

Confocal microscopy image from the Sampognaro Lab
Lab news

Recent updates

August 2026 · New preprint

PQLC2 & lysosomal pH

Our new preprint identifies PQLC2 as a regulator of lysosomal acidification and links it to tau homeostasis.

January 2026 · New publication

APP degradation & pH

Now published in Molecular Neurodegeneration Advances: cathepsin cleavage of APP is pH-dependent.

January 2026 · New publication

Prosaposin & progranulin

Now published in the Journal of Neurochemistry: progranulin regulates cathepsin D cleavage of prosaposin.

See all lab news →

Where we work

UCSF Mission Bay, San Francisco

The lab is in the Weill Institute for Neurosciences building on UCSF's Mission Bay campus.

1651 4th Street, Room 421A
San Francisco, CA 94158

Exterior of the Weill Institute for Neurosciences building at UCSF Mission Bay at dusk
The Weill Institute for Neurosciences building at UCSF Mission Bay.